| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 152 | 2024 | 6268 | 7.640 |
Why?
|
| Air Pollutants | 91 | 2025 | 2923 | 6.030 |
Why?
|
| Air Pollution | 82 | 2024 | 2380 | 5.980 |
Why?
|
| Particulate Matter | 81 | 2024 | 2624 | 5.150 |
Why?
|
| Respiratory Sounds | 47 | 2022 | 706 | 5.110 |
Why?
|
| Air Pollution, Indoor | 50 | 2024 | 931 | 4.420 |
Why?
|
| Environmental Exposure | 104 | 2025 | 4543 | 3.990 |
Why?
|
| Allergens | 62 | 2024 | 1436 | 3.950 |
Why?
|
| Hypersensitivity | 29 | 2023 | 1168 | 2.650 |
Why?
|
| Endotoxins | 18 | 2017 | 516 | 2.430 |
Why?
|
| Dust | 32 | 2022 | 489 | 2.320 |
Why?
|
| Hypersensitivity, Immediate | 20 | 2019 | 346 | 2.180 |
Why?
|
| Vehicle Emissions | 21 | 2024 | 651 | 2.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 27 | 2024 | 2532 | 2.100 |
Why?
|
| Fetal Blood | 29 | 2024 | 1364 | 2.030 |
Why?
|
| Schools | 27 | 2024 | 1495 | 1.980 |
Why?
|
| Immunoglobulin E | 32 | 2022 | 1480 | 1.820 |
Why?
|
| Maternal Exposure | 15 | 2024 | 1096 | 1.610 |
Why?
|
| Ozone | 23 | 2025 | 499 | 1.530 |
Why?
|
| Environmental Monitoring | 28 | 2024 | 1470 | 1.500 |
Why?
|
| Inhalation Exposure | 15 | 2020 | 432 | 1.450 |
Why?
|
| Fluorocarbons | 13 | 2024 | 497 | 1.440 |
Why?
|
| Urban Population | 31 | 2024 | 2040 | 1.350 |
Why?
|
| Humidity | 9 | 2024 | 206 | 1.350 |
Why?
|
| Housing | 24 | 2022 | 683 | 1.240 |
Why?
|
| Fungi | 10 | 2022 | 347 | 1.230 |
Why?
|
| Environmental Pollutants | 15 | 2024 | 1292 | 1.180 |
Why?
|
| Blood Pressure | 15 | 2020 | 8532 | 1.180 |
Why?
|
| Particle Size | 28 | 2021 | 1632 | 1.180 |
Why?
|
| Eczema | 12 | 2012 | 246 | 1.170 |
Why?
|
| Respiratory Tract Infections | 10 | 2024 | 1008 | 1.170 |
Why?
|
| Child | 164 | 2025 | 80509 | 1.140 |
Why?
|
| Antigens, Dermatophagoides | 13 | 2017 | 101 | 1.100 |
Why?
|
| Nitrogen Dioxide | 19 | 2025 | 538 | 1.080 |
Why?
|
| Forced Expiratory Volume | 24 | 2025 | 1827 | 1.060 |
Why?
|
| Urban Health | 12 | 2017 | 530 | 1.040 |
Why?
|
| Child, Preschool | 108 | 2024 | 42478 | 1.030 |
Why?
|
| Temperature | 10 | 2024 | 2226 | 0.940 |
Why?
|
| DNA Methylation | 17 | 2024 | 4424 | 0.940 |
Why?
|
| Female | 308 | 2025 | 396050 | 0.920 |
Why?
|
| Alkanesulfonic Acids | 8 | 2021 | 199 | 0.920 |
Why?
|
| Food Hypersensitivity | 10 | 2022 | 737 | 0.910 |
Why?
|
| Interleukin-13 | 9 | 2017 | 388 | 0.910 |
Why?
|
| Heart Rate | 22 | 2021 | 4202 | 0.890 |
Why?
|
| Cohort Studies | 92 | 2024 | 41643 | 0.890 |
Why?
|
| Nitric Oxide | 10 | 2025 | 2143 | 0.870 |
Why?
|
| Humans | 419 | 2025 | 765823 | 0.870 |
Why?
|
| Pregnancy | 78 | 2024 | 30215 | 0.860 |
Why?
|
| Male | 286 | 2025 | 363740 | 0.860 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2018 | 565 | 0.850 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2020 | 2255 | 0.840 |
Why?
|
| Seasons | 17 | 2024 | 1523 | 0.840 |
Why?
|
| Infant | 83 | 2024 | 36375 | 0.800 |
Why?
|
| Lung | 21 | 2025 | 10031 | 0.800 |
Why?
|
| Boston | 42 | 2025 | 9336 | 0.790 |
Why?
|
| Oxidants, Photochemical | 6 | 2017 | 77 | 0.780 |
Why?
|
| Nasal Mucosa | 3 | 2021 | 416 | 0.750 |
Why?
|
| Electrocardiography, Ambulatory | 12 | 2009 | 582 | 0.740 |
Why?
|
| Vitamin D | 13 | 2024 | 3272 | 0.710 |
Why?
|
| Inflammation | 16 | 2023 | 10845 | 0.700 |
Why?
|
| Docosahexaenoic Acids | 2 | 2018 | 916 | 0.690 |
Why?
|
| Cats | 18 | 2017 | 972 | 0.690 |
Why?
|
| Nickel | 1 | 2020 | 126 | 0.680 |
Why?
|
| Dietary Supplements | 9 | 2024 | 3425 | 0.680 |
Why?
|
| Carbon | 15 | 2024 | 676 | 0.680 |
Why?
|
| Infant, Newborn | 58 | 2023 | 26337 | 0.660 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 2 | 2017 | 62 | 0.590 |
Why?
|
| beta-Glucans | 2 | 2017 | 129 | 0.580 |
Why?
|
| Poverty | 8 | 2024 | 2714 | 0.580 |
Why?
|
| Child Day Care Centers | 4 | 2005 | 122 | 0.580 |
Why?
|
| Hypertension | 8 | 2024 | 8625 | 0.580 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2017 | 7 | 0.570 |
Why?
|
| Pest Control | 1 | 2017 | 29 | 0.570 |
Why?
|
| Linear Models | 23 | 2025 | 5873 | 0.560 |
Why?
|
| Exhalation | 4 | 2023 | 184 | 0.540 |
Why?
|
| Adolescent | 83 | 2025 | 88794 | 0.540 |
Why?
|
| Organizations, Nonprofit | 1 | 2017 | 105 | 0.540 |
Why?
|
| Cytokines | 13 | 2024 | 7425 | 0.540 |
Why?
|
| Fetal Development | 5 | 2018 | 777 | 0.530 |
Why?
|
| Caprylates | 5 | 2021 | 114 | 0.530 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2022 | 1042 | 0.520 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 325 | 0.520 |
Why?
|
| Dermatitis, Atopic | 5 | 2024 | 728 | 0.520 |
Why?
|
| Pre-Eclampsia | 3 | 2024 | 1256 | 0.510 |
Why?
|
| Brachial Artery | 3 | 2014 | 376 | 0.510 |
Why?
|
| Longitudinal Studies | 35 | 2019 | 14745 | 0.500 |
Why?
|
| Airway Obstruction | 2 | 2020 | 665 | 0.500 |
Why?
|
| Radioactivity | 3 | 2020 | 59 | 0.500 |
Why?
|
| Health Status Disparities | 3 | 2024 | 1879 | 0.490 |
Why?
|
| Vitamins | 5 | 2024 | 1631 | 0.490 |
Why?
|
| Soot | 9 | 2024 | 219 | 0.480 |
Why?
|
| Risk Factors | 74 | 2023 | 74853 | 0.480 |
Why?
|
| Prospective Studies | 57 | 2024 | 54798 | 0.480 |
Why?
|
| Cockroaches | 13 | 2017 | 93 | 0.470 |
Why?
|
| Cities | 9 | 2024 | 543 | 0.460 |
Why?
|
| Respiratory Function Tests | 13 | 2020 | 1692 | 0.450 |
Why?
|
| Prediabetic State | 4 | 2021 | 547 | 0.450 |
Why?
|
| Metals | 3 | 2024 | 710 | 0.450 |
Why?
|
| Body Mass Index | 17 | 2023 | 13041 | 0.440 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2024 | 983 | 0.440 |
Why?
|
| Obesity | 14 | 2021 | 13078 | 0.440 |
Why?
|
| School Health Services | 1 | 2017 | 389 | 0.430 |
Why?
|
| Sex Factors | 13 | 2021 | 10607 | 0.430 |
Why?
|
| Antigens, Fungal | 1 | 2013 | 69 | 0.430 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2013 | 57 | 0.420 |
Why?
|
| Climate | 2 | 2013 | 146 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2016 | 3247 | 0.420 |
Why?
|
| Adult | 122 | 2024 | 223055 | 0.420 |
Why?
|
| Breath Tests | 7 | 2024 | 297 | 0.410 |
Why?
|
| Cardiovascular Diseases | 18 | 2021 | 15645 | 0.410 |
Why?
|
| Residence Characteristics | 11 | 2024 | 2115 | 0.400 |
Why?
|
| Tobacco Smoke Pollution | 10 | 2018 | 828 | 0.400 |
Why?
|
| Leukocytes, Mononuclear | 10 | 2020 | 1856 | 0.390 |
Why?
|
| Skin Tests | 9 | 2017 | 630 | 0.380 |
Why?
|
| Socioeconomic Factors | 13 | 2024 | 7840 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2021 | 12235 | 0.370 |
Why?
|
| Massachusetts | 28 | 2024 | 8875 | 0.370 |
Why?
|
| Eating | 1 | 2018 | 1538 | 0.360 |
Why?
|
| Snoring | 2 | 2024 | 212 | 0.360 |
Why?
|
| Cholecalciferol | 1 | 2016 | 550 | 0.360 |
Why?
|
| Vital Capacity | 14 | 2025 | 994 | 0.350 |
Why?
|
| Dogs | 14 | 2017 | 3824 | 0.350 |
Why?
|
| Drug Industry | 1 | 2017 | 791 | 0.350 |
Why?
|
| Adiposity | 7 | 2021 | 1890 | 0.340 |
Why?
|
| Rhinitis | 3 | 2014 | 752 | 0.340 |
Why?
|
| Vasodilation | 2 | 2014 | 970 | 0.340 |
Why?
|
| Immunity, Active | 1 | 2009 | 58 | 0.330 |
Why?
|
| Cysteine Endopeptidases | 5 | 2017 | 542 | 0.330 |
Why?
|
| United States | 44 | 2024 | 72896 | 0.330 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2018 | 1881 | 0.330 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 4 | 2016 | 160 | 0.330 |
Why?
|
| Mites | 8 | 2017 | 46 | 0.330 |
Why?
|
| Child Development | 6 | 2019 | 2327 | 0.320 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 3815 | 0.320 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2020 | 737 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 416 | 0.320 |
Why?
|
| Arsenic | 2 | 2024 | 357 | 0.320 |
Why?
|
| Fatty Acids, Omega-3 | 6 | 2024 | 1396 | 0.310 |
Why?
|
| Overweight | 6 | 2021 | 2443 | 0.310 |
Why?
|
| Lymphocytes | 5 | 2024 | 2601 | 0.310 |
Why?
|
| Oxidative Stress | 6 | 2019 | 3139 | 0.310 |
Why?
|
| Follow-Up Studies | 26 | 2021 | 39226 | 0.300 |
Why?
|
| Middle Aged | 81 | 2024 | 223016 | 0.300 |
Why?
|
| Air Pollutants, Radioactive | 2 | 2019 | 55 | 0.300 |
Why?
|
| Fibrinogen | 2 | 2022 | 897 | 0.300 |
Why?
|
| Oxygen | 2 | 2014 | 4242 | 0.300 |
Why?
|
| Diet | 13 | 2024 | 8085 | 0.300 |
Why?
|
| Morbidity | 10 | 2021 | 1752 | 0.290 |
Why?
|
| Respiratory Tract Diseases | 5 | 2017 | 744 | 0.290 |
Why?
|
| Bronchodilator Agents | 3 | 2013 | 514 | 0.290 |
Why?
|
| Life Style | 8 | 2021 | 3929 | 0.280 |
Why?
|
| Interferon-gamma | 7 | 2017 | 3160 | 0.280 |
Why?
|
| Heart Conduction System | 2 | 2011 | 1006 | 0.280 |
Why?
|
| Mothers | 7 | 2023 | 2207 | 0.280 |
Why?
|
| Blattellidae | 2 | 2013 | 3 | 0.280 |
Why?
|
| Multivariate Analysis | 17 | 2019 | 12056 | 0.270 |
Why?
|
| Carbon Monoxide | 8 | 2019 | 560 | 0.270 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2013 | 271 | 0.270 |
Why?
|
| Maternal-Fetal Exchange | 5 | 2020 | 453 | 0.270 |
Why?
|
| Aged | 65 | 2024 | 171178 | 0.270 |
Why?
|
| Alternaria | 2 | 2019 | 41 | 0.270 |
Why?
|
| Spores, Fungal | 3 | 2019 | 90 | 0.270 |
Why?
|
| Infant Food | 2 | 2005 | 139 | 0.260 |
Why?
|
| Autonomic Nervous System | 6 | 2017 | 706 | 0.260 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3563 | 0.250 |
Why?
|
| Milk | 3 | 2022 | 436 | 0.250 |
Why?
|
| Endocrine Disruptors | 2 | 2019 | 249 | 0.250 |
Why?
|
| Aged, 80 and over | 30 | 2020 | 59506 | 0.250 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 392 | 0.250 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1587 | 0.250 |
Why?
|
| Hypotension | 1 | 2011 | 883 | 0.250 |
Why?
|
| Bacteria | 4 | 2019 | 2209 | 0.250 |
Why?
|
| Ohio | 4 | 2014 | 320 | 0.250 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 143 | 0.240 |
Why?
|
| Gestational Age | 7 | 2023 | 3614 | 0.240 |
Why?
|
| Leukocytes | 1 | 2013 | 2027 | 0.240 |
Why?
|
| Body Weights and Measures | 2 | 2017 | 208 | 0.240 |
Why?
|
| Bayes Theorem | 7 | 2021 | 2353 | 0.240 |
Why?
|
| Prevalence | 18 | 2024 | 15832 | 0.240 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2006 | 300 | 0.240 |
Why?
|
| Logistic Models | 17 | 2016 | 13266 | 0.240 |
Why?
|
| Accidents, Occupational | 2 | 2000 | 251 | 0.240 |
Why?
|
| Animals | 55 | 2022 | 168730 | 0.240 |
Why?
|
| Sex Characteristics | 3 | 2016 | 2643 | 0.230 |
Why?
|
| Pneumonia | 2 | 2016 | 2156 | 0.230 |
Why?
|
| Epigenomics | 3 | 2019 | 959 | 0.230 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 648 | 0.230 |
Why?
|
| Young Adult | 31 | 2024 | 59849 | 0.230 |
Why?
|
| Cross-Over Studies | 9 | 2017 | 2108 | 0.230 |
Why?
|
| Interleukin-6 | 3 | 2017 | 3228 | 0.220 |
Why?
|
| Automobile Driving | 1 | 2009 | 441 | 0.220 |
Why?
|
| Phenols | 2 | 2024 | 522 | 0.220 |
Why?
|
| Feeding Behavior | 4 | 2017 | 3210 | 0.220 |
Why?
|
| Weather | 5 | 2016 | 234 | 0.220 |
Why?
|
| Acculturation | 1 | 2005 | 179 | 0.220 |
Why?
|
| Pollen | 1 | 2024 | 79 | 0.220 |
Why?
|
| Hyperemia | 2 | 2016 | 224 | 0.220 |
Why?
|
| Spirometry | 8 | 2022 | 928 | 0.220 |
Why?
|
| Metabolome | 3 | 2022 | 1005 | 0.220 |
Why?
|
| Odds Ratio | 16 | 2022 | 9653 | 0.220 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5501 | 0.220 |
Why?
|
| Dyspnea | 3 | 2014 | 1351 | 0.220 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 1811 | 0.220 |
Why?
|
| Sleep | 4 | 2019 | 4819 | 0.220 |
Why?
|
| Nitrogen Oxides | 4 | 2017 | 128 | 0.210 |
Why?
|
| Fishes | 2 | 2013 | 607 | 0.210 |
Why?
|
| Antioxidants | 2 | 2013 | 1670 | 0.210 |
Why?
|
| Phenotype | 9 | 2022 | 16706 | 0.210 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2011 | 226 | 0.210 |
Why?
|
| Pyroglyphidae | 3 | 2009 | 94 | 0.210 |
Why?
|
| Decanoic Acids | 2 | 2021 | 68 | 0.210 |
Why?
|
| Stress, Psychological | 4 | 2021 | 4528 | 0.210 |
Why?
|
| Mice | 16 | 2017 | 81788 | 0.210 |
Why?
|
| Birth Weight | 8 | 2021 | 2121 | 0.210 |
Why?
|
| Insect Proteins | 2 | 2006 | 253 | 0.200 |
Why?
|
| Heart Diseases | 2 | 2013 | 2818 | 0.200 |
Why?
|
| Parents | 8 | 2018 | 3590 | 0.200 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 47 | 0.200 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 26276 | 0.200 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2003 | 112 | 0.200 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 405 | 0.200 |
Why?
|
| Endogenous Retroviruses | 1 | 2023 | 111 | 0.200 |
Why?
|
| Sulfates | 5 | 2017 | 375 | 0.190 |
Why?
|
| Folic Acid | 3 | 2017 | 1337 | 0.190 |
Why?
|
| Sulfur Dioxide | 6 | 2014 | 178 | 0.190 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.190 |
Why?
|
| CpG Islands | 4 | 2019 | 1207 | 0.190 |
Why?
|
| Beta Particles | 2 | 2020 | 52 | 0.190 |
Why?
|
| Parabens | 2 | 2024 | 117 | 0.190 |
Why?
|
| Myocardial Ischemia | 2 | 2009 | 2129 | 0.190 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1318 | 0.190 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 2016 | 143 | 0.190 |
Why?
|
| Child Welfare | 2 | 2004 | 521 | 0.190 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 83 | 0.180 |
Why?
|
| Fetal Growth Retardation | 2 | 2016 | 591 | 0.180 |
Why?
|
| Rhinitis, Allergic, Seasonal | 4 | 2024 | 101 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2011 | 3078 | 0.180 |
Why?
|
| Regression Analysis | 13 | 2016 | 6320 | 0.180 |
Why?
|
| Puberty | 1 | 2004 | 491 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2022 | 694 | 0.180 |
Why?
|
| Glutathione Transferase | 3 | 2013 | 562 | 0.180 |
Why?
|
| Environmental Health | 4 | 2019 | 297 | 0.180 |
Why?
|
| Sphingolipids | 2 | 2022 | 177 | 0.180 |
Why?
|
| Caregivers | 3 | 2024 | 2304 | 0.180 |
Why?
|
| Genome-Wide Association Study | 7 | 2023 | 12800 | 0.180 |
Why?
|
| Incidence | 16 | 2024 | 21501 | 0.170 |
Why?
|
| Pregnancy Complications | 6 | 2024 | 2970 | 0.170 |
Why?
|
| gamma-Tocopherol | 1 | 2020 | 29 | 0.170 |
Why?
|
| Pregnancy Trimesters | 2 | 2019 | 197 | 0.170 |
Why?
|
| Pregnancy Trimester, First | 5 | 2024 | 917 | 0.170 |
Why?
|
| Metals, Heavy | 1 | 2021 | 151 | 0.170 |
Why?
|
| Breast Feeding | 7 | 2018 | 1363 | 0.170 |
Why?
|
| Decompression Sickness | 1 | 2000 | 16 | 0.170 |
Why?
|
| Population Surveillance | 5 | 2019 | 2595 | 0.170 |
Why?
|
| Antigens, Plant | 5 | 2004 | 103 | 0.170 |
Why?
|
| Diving | 1 | 2000 | 43 | 0.170 |
Why?
|
| Lactococcus | 1 | 2019 | 3 | 0.170 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1885 | 0.170 |
Why?
|
| Gram-Negative Bacteria | 3 | 2010 | 275 | 0.170 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2022 | 1132 | 0.170 |
Why?
|
| alpha-Tocopherol | 1 | 2020 | 127 | 0.170 |
Why?
|
| Actinomycetales | 1 | 2019 | 33 | 0.160 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2017 | 309 | 0.160 |
Why?
|
| Diabetes, Gestational | 3 | 2020 | 1263 | 0.160 |
Why?
|
| Mexico | 9 | 2013 | 771 | 0.160 |
Why?
|
| Health Services | 2 | 2017 | 756 | 0.160 |
Why?
|
| Gram-Positive Bacteria | 2 | 2010 | 180 | 0.160 |
Why?
|
| Bone Density | 2 | 2024 | 3490 | 0.160 |
Why?
|
| Atrial Fibrillation | 5 | 2022 | 5187 | 0.160 |
Why?
|
| Trace Elements | 1 | 2020 | 193 | 0.160 |
Why?
|
| Environmental Illness | 1 | 2019 | 33 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 587 | 0.160 |
Why?
|
| Dietary Fats | 3 | 2018 | 2002 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4404 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 237 | 0.160 |
Why?
|
| Budesonide | 2 | 2013 | 163 | 0.160 |
Why?
|
| Sulfur | 1 | 2019 | 158 | 0.160 |
Why?
|
| Biomass | 1 | 2019 | 136 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2006 | 1806 | 0.160 |
Why?
|
| Age Factors | 15 | 2021 | 18380 | 0.160 |
Why?
|
| Social Class | 3 | 2005 | 2009 | 0.150 |
Why?
|
| Mitogens | 5 | 2024 | 228 | 0.150 |
Why?
|
| Proteobacteria | 1 | 2018 | 47 | 0.150 |
Why?
|
| Time Factors | 22 | 2020 | 40109 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2018 | 538 | 0.150 |
Why?
|
| Immunization | 3 | 2017 | 1218 | 0.150 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 531 | 0.150 |
Why?
|
| Proteoglycans | 3 | 2017 | 793 | 0.150 |
Why?
|
| Oxidants | 1 | 2018 | 166 | 0.150 |
Why?
|
| Caffeine | 1 | 2022 | 702 | 0.150 |
Why?
|
| Risk Assessment | 16 | 2018 | 24278 | 0.150 |
Why?
|
| Masks | 1 | 2020 | 209 | 0.150 |
Why?
|
| Age Distribution | 5 | 2003 | 2865 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 939 | 0.150 |
Why?
|
| Exercise Test | 2 | 2005 | 2184 | 0.140 |
Why?
|
| Violence | 1 | 2004 | 934 | 0.140 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2017 | 29 | 0.140 |
Why?
|
| Double-Blind Method | 6 | 2024 | 12421 | 0.140 |
Why?
|
| Netherlands | 2 | 2021 | 2277 | 0.140 |
Why?
|
| Interleukin-10 | 3 | 2008 | 1183 | 0.140 |
Why?
|
| Pandemics | 3 | 2023 | 8698 | 0.140 |
Why?
|
| Triclosan | 1 | 2017 | 59 | 0.140 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 531 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2741 | 0.140 |
Why?
|
| Confidence Intervals | 5 | 2017 | 2914 | 0.140 |
Why?
|
| Fund Raising | 1 | 2017 | 48 | 0.140 |
Why?
|
| Wood | 1 | 2017 | 94 | 0.140 |
Why?
|
| Climate Change | 1 | 2023 | 509 | 0.140 |
Why?
|
| Heating | 1 | 2017 | 103 | 0.130 |
Why?
|
| Peroxidase | 2 | 2016 | 604 | 0.130 |
Why?
|
| Sex | 1 | 2016 | 53 | 0.130 |
Why?
|
| Cognition | 4 | 2018 | 7045 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 520 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2010 | 4350 | 0.130 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 385 | 0.130 |
Why?
|
| Metabolomics | 3 | 2022 | 1668 | 0.130 |
Why?
|
| Health Promotion | 3 | 2023 | 2208 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 139 | 0.130 |
Why?
|
| Thyrotropin | 1 | 2019 | 835 | 0.130 |
Why?
|
| Thyroxine | 1 | 2019 | 665 | 0.130 |
Why?
|
| Fructose | 1 | 2018 | 285 | 0.130 |
Why?
|
| Adipokines | 1 | 2017 | 308 | 0.120 |
Why?
|
| Body Composition | 2 | 2021 | 2441 | 0.120 |
Why?
|
| Microvessels | 2 | 2019 | 589 | 0.120 |
Why?
|
| Dermatophagoides farinae | 1 | 2015 | 19 | 0.120 |
Why?
|
| Smoke | 1 | 2017 | 243 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2018 | 291 | 0.120 |
Why?
|
| Cold Temperature | 3 | 2017 | 794 | 0.120 |
Why?
|
| Animals, Domestic | 3 | 2004 | 56 | 0.120 |
Why?
|
| Aging | 8 | 2024 | 8731 | 0.120 |
Why?
|
| Family Characteristics | 3 | 2023 | 1001 | 0.120 |
Why?
|
| Psychology | 1 | 2017 | 354 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 833 | 0.120 |
Why?
|
| Biometry | 2 | 2009 | 571 | 0.120 |
Why?
|
| Analysis of Variance | 6 | 2015 | 6204 | 0.120 |
Why?
|
| Interleukin-9 | 1 | 2015 | 63 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 318 | 0.120 |
Why?
|
| Administration, Inhalation | 2 | 2009 | 1154 | 0.120 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 299 | 0.120 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 206 | 0.120 |
Why?
|
| Maximal Midexpiratory Flow Rate | 7 | 2013 | 75 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 979 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3421 | 0.120 |
Why?
|
| Seafood | 2 | 2020 | 395 | 0.120 |
Why?
|
| Models, Statistical | 9 | 2015 | 5089 | 0.120 |
Why?
|
| Coronary Artery Disease | 3 | 2009 | 6544 | 0.110 |
Why?
|
| Glucose | 3 | 2017 | 4332 | 0.110 |
Why?
|
| Cladosporium | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2024 | 10428 | 0.110 |
Why?
|
| Hospitalization | 8 | 2021 | 10803 | 0.110 |
Why?
|
| Acute Disease | 5 | 2016 | 7237 | 0.110 |
Why?
|
| Polysomnography | 3 | 2024 | 1868 | 0.110 |
Why?
|
| Penicillium | 1 | 2013 | 23 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 579 | 0.110 |
Why?
|
| Vitamin E | 1 | 2018 | 870 | 0.110 |
Why?
|
| Triticum | 1 | 2014 | 92 | 0.110 |
Why?
|
| Total Lung Capacity | 1 | 2013 | 148 | 0.110 |
Why?
|
| Finland | 3 | 2019 | 608 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2022 | 18064 | 0.110 |
Why?
|
| Aspergillus | 1 | 2013 | 93 | 0.110 |
Why?
|
| Nedocromil | 1 | 2013 | 45 | 0.110 |
Why?
|
| Predictive Value of Tests | 7 | 2014 | 15398 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2014 | 124 | 0.110 |
Why?
|
| Smoking | 9 | 2023 | 9081 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 401 | 0.110 |
Why?
|
| C-Reactive Protein | 5 | 2022 | 3851 | 0.110 |
Why?
|
| Diabetes Mellitus | 4 | 2015 | 5889 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 228 | 0.100 |
Why?
|
| Papilledema | 1 | 2014 | 130 | 0.100 |
Why?
|
| Immune System | 2 | 2011 | 799 | 0.100 |
Why?
|
| Fingers | 1 | 2016 | 509 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1181 | 0.100 |
Why?
|
| Feces | 4 | 2022 | 1503 | 0.100 |
Why?
|
| Schistosomiasis mansoni | 1 | 1993 | 94 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 216 | 0.100 |
Why?
|
| Research Design | 3 | 2019 | 6207 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3099 | 0.100 |
Why?
|
| Disease Susceptibility | 5 | 2012 | 1788 | 0.100 |
Why?
|
| Night Care | 1 | 1992 | 28 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3222 | 0.100 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 527 | 0.100 |
Why?
|
| Disease Progression | 4 | 2019 | 13613 | 0.100 |
Why?
|
| Beverages | 1 | 2018 | 819 | 0.100 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2011 | 23 | 0.100 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 1991 | 217 | 0.100 |
Why?
|
| Genetic Variation | 3 | 2021 | 6607 | 0.100 |
Why?
|
| Defibrillators, Implantable | 5 | 2015 | 1497 | 0.100 |
Why?
|
| Community Networks | 1 | 2013 | 202 | 0.100 |
Why?
|
| Family | 2 | 2017 | 3208 | 0.100 |
Why?
|
| Ontario | 3 | 2018 | 402 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1624 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 100 | 0.100 |
Why?
|
| Depression | 4 | 2021 | 8224 | 0.090 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2017 | 492 | 0.090 |
Why?
|
| Recurrence | 8 | 2014 | 8506 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2009 | 2719 | 0.090 |
Why?
|
| Enzymes | 1 | 2013 | 254 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2014 | 367 | 0.090 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 1794 | 0.090 |
Why?
|
| Drug Combinations | 2 | 2016 | 2074 | 0.090 |
Why?
|
| Papillomaviridae | 1 | 2017 | 1137 | 0.090 |
Why?
|
| Orbit | 1 | 2014 | 458 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2017 | 808 | 0.090 |
Why?
|
| Disabled Persons | 2 | 2001 | 1208 | 0.090 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 4526 | 0.090 |
Why?
|
| Diabetic Angiopathies | 2 | 2006 | 805 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2112 | 0.090 |
Why?
|
| Glycoproteins | 5 | 2003 | 2195 | 0.090 |
Why?
|
| Oximetry | 1 | 2014 | 458 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2009 | 355 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 342 | 0.090 |
Why?
|
| Environment Design | 1 | 2012 | 174 | 0.090 |
Why?
|
| Air Microbiology | 2 | 2019 | 94 | 0.090 |
Why?
|
| Muramic Acids | 1 | 2010 | 2 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2003 | 2268 | 0.090 |
Why?
|
| Body Weight | 3 | 2018 | 4624 | 0.090 |
Why?
|
| Stroke | 4 | 2013 | 9749 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2015 | 9355 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2014 | 548 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2015 | 703 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 939 | 0.090 |
Why?
|
| Environment | 2 | 2014 | 1116 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 305 | 0.090 |
Why?
|
| Optic Disk | 1 | 2014 | 420 | 0.090 |
Why?
|
| Cesarean Section | 3 | 2022 | 1418 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1519 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1438 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2018 | 1620 | 0.080 |
Why?
|
| Health Personnel | 1 | 2023 | 3386 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1242 | 0.080 |
Why?
|
| Ergosterol | 1 | 2009 | 19 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 657 | 0.080 |
Why?
|
| Microcirculation | 1 | 2014 | 1279 | 0.080 |
Why?
|
| Hot Temperature | 2 | 2017 | 1433 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2022 | 16040 | 0.080 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1989 | 309 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2017 | 1387 | 0.080 |
Why?
|
| Age of Onset | 2 | 2008 | 3341 | 0.080 |
Why?
|
| Safety | 1 | 2014 | 1158 | 0.080 |
Why?
|
| Nursing Staff, Hospital | 1 | 1992 | 350 | 0.080 |
Why?
|
| Infant Formula | 2 | 2022 | 192 | 0.080 |
Why?
|
| Exercise | 6 | 2018 | 5937 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 368 | 0.080 |
Why?
|
| Anxiety | 2 | 2023 | 4670 | 0.080 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2009 | 168 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2012 | 302 | 0.080 |
Why?
|
| American Heart Association | 1 | 2013 | 1046 | 0.070 |
Why?
|
| Bronchiolitis | 1 | 2014 | 492 | 0.070 |
Why?
|
| Lung Diseases | 4 | 2012 | 1939 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 1992 | 553 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2010 | 1731 | 0.070 |
Why?
|
| Lipids | 1 | 2019 | 3316 | 0.070 |
Why?
|
| Electrocardiography | 7 | 2017 | 6408 | 0.070 |
Why?
|
| Occupational Diseases | 3 | 1993 | 1456 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 3802 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4849 | 0.070 |
Why?
|
| Motor Vehicles | 1 | 2009 | 280 | 0.070 |
Why?
|
| Executive Function | 1 | 2016 | 1391 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2020 | 3682 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1907 | 0.070 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 269 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 3690 | 0.070 |
Why?
|
| Disaccharides | 1 | 2008 | 170 | 0.070 |
Why?
|
| New England | 2 | 2013 | 1059 | 0.070 |
Why?
|
| Bronchial Provocation Tests | 2 | 2006 | 217 | 0.070 |
Why?
|
| Peptidoglycan | 2 | 2006 | 246 | 0.070 |
Why?
|
| Health Surveys | 3 | 2019 | 4058 | 0.070 |
Why?
|
| Probiotics | 1 | 2011 | 387 | 0.070 |
Why?
|
| World Health Organization | 1 | 2013 | 1326 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2006 | 347 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1248 | 0.070 |
Why?
|
| Pilot Projects | 5 | 2018 | 8725 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 1988 | 328 | 0.070 |
Why?
|
| Data Collection | 2 | 2002 | 3317 | 0.070 |
Why?
|
| Floors and Floorcoverings | 2 | 2004 | 27 | 0.070 |
Why?
|
| Longevity | 2 | 2023 | 1087 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 1993 | 1896 | 0.070 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 78 | 0.070 |
Why?
|
| United States Environmental Protection Agency | 2 | 2019 | 139 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2015 | 1164 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2017 | 2213 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3987 | 0.070 |
Why?
|
| Cell Separation | 1 | 2011 | 1718 | 0.060 |
Why?
|
| Methacholine Chloride | 1 | 2006 | 220 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2184 | 0.060 |
Why?
|
| Risk | 5 | 2019 | 9600 | 0.060 |
Why?
|
| Reference Values | 4 | 2012 | 4911 | 0.060 |
Why?
|
| Genotype | 6 | 2023 | 13023 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 150 | 0.060 |
Why?
|
| Mortality | 3 | 2020 | 2910 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 1989 | 364 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3584 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2013 | 840 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2817 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5368 | 0.060 |
Why?
|
| Suburban Population | 1 | 2005 | 54 | 0.060 |
Why?
|
| Polysorbates | 1 | 2005 | 46 | 0.060 |
Why?
|
| Retrospective Studies | 12 | 2019 | 81505 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1637 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 5529 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2007 | 364 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2009 | 893 | 0.060 |
Why?
|
| Vasoconstriction | 2 | 2005 | 594 | 0.060 |
Why?
|
| Meteorological Concepts | 1 | 2004 | 30 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2036 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 834 | 0.060 |
Why?
|
| Russia | 1 | 2005 | 383 | 0.060 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 583 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2269 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 1990 | 1078 | 0.060 |
Why?
|
| Hygiene | 1 | 2005 | 95 | 0.060 |
Why?
|
| Birth Order | 1 | 2005 | 93 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2355 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1312 | 0.060 |
Why?
|
| Androstadienes | 1 | 2006 | 347 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 165 | 0.060 |
Why?
|
| Statistics as Topic | 2 | 2003 | 2350 | 0.060 |
Why?
|
| Arizona | 1 | 2004 | 108 | 0.060 |
Why?
|
| Biodiversity | 2 | 2017 | 344 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15881 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 869 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9520 | 0.060 |
Why?
|
| Fungal Structures | 1 | 2003 | 2 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7476 | 0.050 |
Why?
|
| Students | 4 | 2015 | 1739 | 0.050 |
Why?
|
| Chicago | 1 | 2004 | 255 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2009 | 1590 | 0.050 |
Why?
|
| Washington | 1 | 2004 | 314 | 0.050 |
Why?
|
| Body Height | 3 | 2008 | 1561 | 0.050 |
Why?
|
| Denmark | 2 | 2018 | 774 | 0.050 |
Why?
|
| Filtration | 2 | 2017 | 226 | 0.050 |
Why?
|
| Infant Equipment | 1 | 2002 | 23 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 382 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 1986 | 470 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2017 | 6422 | 0.050 |
Why?
|
| Texas | 1 | 2004 | 410 | 0.050 |
Why?
|
| Manometry | 2 | 2016 | 457 | 0.050 |
Why?
|
| Vasculitis | 1 | 2006 | 523 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 4249 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1405 | 0.050 |
Why?
|
| Self Report | 3 | 2022 | 3768 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 128 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1727 | 0.050 |
Why?
|
| Systole | 1 | 2004 | 935 | 0.050 |
Why?
|
| Circadian Rhythm | 2 | 1999 | 2595 | 0.050 |
Why?
|
| Diastole | 1 | 2004 | 785 | 0.050 |
Why?
|
| Brain Ischemia | 2 | 2013 | 3001 | 0.050 |
Why?
|
| Costa Rica | 2 | 2015 | 187 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2006 | 1238 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Cryptosporidium | 1 | 2002 | 43 | 0.050 |
Why?
|
| Probability | 2 | 2002 | 2475 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 161 | 0.050 |
Why?
|
| New York City | 1 | 2004 | 734 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3457 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2020 | 1996 | 0.050 |
Why?
|
| Population Density | 1 | 2002 | 193 | 0.050 |
Why?
|
| Soil Microbiology | 1 | 2002 | 92 | 0.050 |
Why?
|
| Cough | 2 | 2003 | 597 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 677 | 0.050 |
Why?
|
| Eggs | 1 | 2022 | 182 | 0.050 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 103 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5879 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 3046 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2008 | 738 | 0.040 |
Why?
|
| Metagenome | 2 | 2017 | 464 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 1188 | 0.040 |
Why?
|
| Neutrophils | 1 | 2013 | 3770 | 0.040 |
Why?
|
| Missouri | 2 | 2007 | 112 | 0.040 |
Why?
|
| Water Supply | 1 | 2002 | 204 | 0.040 |
Why?
|
| Educational Status | 4 | 2018 | 2511 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2003 | 616 | 0.040 |
Why?
|
| Heart Ventricles | 2 | 2011 | 3832 | 0.040 |
Why?
|
| Workers' Compensation | 1 | 2001 | 150 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 10383 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12520 | 0.040 |
Why?
|
| Zinc | 1 | 2024 | 675 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 1991 | 3210 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3271 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1114 | 0.040 |
Why?
|
| Phthalic Acids | 1 | 2024 | 485 | 0.040 |
Why?
|
| Smog | 1 | 1999 | 6 | 0.040 |
Why?
|
| Absenteeism | 1 | 2001 | 247 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 3592 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
| Thailand | 1 | 2000 | 288 | 0.040 |
Why?
|
| Rest | 1 | 2004 | 940 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 200 | 0.040 |
Why?
|
| Nutrition Policy | 1 | 2023 | 467 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 15 | 0.040 |
Why?
|
| Social Environment | 1 | 2004 | 1011 | 0.040 |
Why?
|
| Forecasting | 2 | 2005 | 2938 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2020 | 2137 | 0.040 |
Why?
|
| Comorbidity | 2 | 2004 | 10570 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 100 | 0.040 |
Why?
|
| Culex | 3 | 1969 | 18 | 0.040 |
Why?
|
| Life Change Events | 1 | 2004 | 956 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 498 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 20131 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2009 | 11506 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 100 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2003 | 1391 | 0.040 |
Why?
|
| Milk, Human | 1 | 2022 | 490 | 0.040 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2018 | 113 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 99 | 0.040 |
Why?
|
| Bacteroides | 1 | 2018 | 165 | 0.040 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2001 | 332 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 295 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 2010 | 719 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2017 | 39 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2004 | 937 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2018 | 504 | 0.040 |
Why?
|
| Causality | 1 | 2003 | 1247 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9441 | 0.040 |
Why?
|
| Radiation Monitoring | 1 | 2018 | 106 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2017 | 4133 | 0.030 |
Why?
|
| Otitis Media | 1 | 1999 | 287 | 0.030 |
Why?
|
| Lead | 2 | 2021 | 879 | 0.030 |
Why?
|
| Switzerland | 2 | 2008 | 322 | 0.030 |
Why?
|
| Heart | 2 | 2008 | 4419 | 0.030 |
Why?
|
| Population | 1 | 2017 | 140 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 4056 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 251 | 0.030 |
Why?
|
| Cattle | 1 | 2022 | 3801 | 0.030 |
Why?
|
| Observer Variation | 1 | 2003 | 2611 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 300 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 1313 | 0.030 |
Why?
|
| Thinness | 1 | 2019 | 482 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2004 | 2120 | 0.030 |
Why?
|
| Aerosols | 1 | 2018 | 632 | 0.030 |
Why?
|
| Nicotine | 1 | 2021 | 682 | 0.030 |
Why?
|
| Arteries | 1 | 2021 | 1124 | 0.030 |
Why?
|
| Maternal Age | 3 | 2007 | 804 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2019 | 934 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2487 | 0.030 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1160 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13466 | 0.030 |
Why?
|
| Body Size | 1 | 2018 | 459 | 0.030 |
Why?
|
| Cytomegalovirus | 2 | 1990 | 752 | 0.030 |
Why?
|
| Schistosoma mansoni | 2 | 1993 | 154 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1060 | 0.030 |
Why?
|
| Telomere | 1 | 2021 | 941 | 0.030 |
Why?
|
| Fathers | 1 | 1998 | 377 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2017 | 357 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 347 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2004 | 2019 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 29915 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2005 | 1949 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 790 | 0.030 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 319 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 1349 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 9241 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 991 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 1270 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.030 |
Why?
|
| Spleen | 3 | 2004 | 2296 | 0.030 |
Why?
|
| Pulse | 1 | 2014 | 217 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2002 | 4018 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2024 | 2555 | 0.030 |
Why?
|
| Developed Countries | 1 | 2017 | 452 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 733 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 2968 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2020 | 1529 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1999 | 752 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 380 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1994 | 138 | 0.030 |
Why?
|
| Psychometrics | 1 | 2023 | 3061 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1738 | 0.030 |
Why?
|
| Kansas | 1 | 1993 | 37 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2021 | 7846 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 473 | 0.030 |
Why?
|
| New York | 2 | 2011 | 880 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 455 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13446 | 0.030 |
Why?
|
| Antigens, Helminth | 1 | 1993 | 67 | 0.030 |
Why?
|
| Wisconsin | 1 | 1993 | 121 | 0.030 |
Why?
|
| Tennessee | 1 | 1993 | 123 | 0.030 |
Why?
|
| Medical Audit | 1 | 2015 | 454 | 0.030 |
Why?
|
| Respiration | 1 | 2000 | 1652 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 135 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2015 | 268 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2013 | 326 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 57 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2013 | 26 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4422 | 0.030 |
Why?
|
| Patient Admission | 1 | 2000 | 1364 | 0.030 |
Why?
|
| Income | 2 | 2000 | 1873 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 508 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1993 | 341 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 390 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2013 | 99 | 0.030 |
Why?
|
| Aftercare | 1 | 1999 | 914 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 993 | 0.030 |
Why?
|
| Schistosomiasis | 1 | 1993 | 65 | 0.030 |
Why?
|
| Food | 1 | 2017 | 764 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1476 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 395 | 0.030 |
Why?
|
| Anthropometry | 1 | 2017 | 1339 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2016 | 65223 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2739 | 0.020 |
Why?
|
| Legionnaires' Disease | 1 | 1992 | 50 | 0.020 |
Why?
|
| Gastroenterology | 1 | 1999 | 593 | 0.020 |
Why?
|
| Testis | 1 | 1995 | 781 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2000 | 1187 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2001 | 2570 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2018 | 22227 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2014 | 957 | 0.020 |
Why?
|
| Insect Bites and Stings | 3 | 1969 | 71 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14644 | 0.020 |
Why?
|
| Growth | 1 | 1993 | 365 | 0.020 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 1992 | 62 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 936 | 0.020 |
Why?
|
| Public Health | 1 | 2005 | 2678 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 974 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 624 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6893 | 0.020 |
Why?
|
| Kidney | 3 | 2021 | 7073 | 0.020 |
Why?
|
| Entamoeba histolytica | 2 | 1981 | 28 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 895 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2194 | 0.020 |
Why?
|
| Skinfold Thickness | 1 | 2011 | 164 | 0.020 |
Why?
|
| Formaldehyde | 1 | 1992 | 354 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2016 | 960 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 232 | 0.020 |
Why?
|
| Walking | 1 | 1998 | 1198 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 3435 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 1993 | 380 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1916 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 552 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1037 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2015 | 555 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 2687 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
| Cholesterol | 1 | 2019 | 2898 | 0.020 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1989 | 77 | 0.020 |
Why?
|
| Dehydrocholesterols | 1 | 2009 | 20 | 0.020 |
Why?
|
| Herpesvirus 6, Human | 1 | 1990 | 98 | 0.020 |
Why?
|
| Th1 Cells | 2 | 2005 | 1039 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1390 | 0.020 |
Why?
|
| Growth Disorders | 1 | 1994 | 633 | 0.020 |
Why?
|
| Th2 Cells | 2 | 2005 | 1075 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2015 | 18970 | 0.020 |
Why?
|
| Maternal-Fetal Relations | 1 | 2009 | 25 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2017 | 1157 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2222 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5127 | 0.020 |
Why?
|
| Encephalitis | 1 | 2012 | 440 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 451 | 0.020 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1992 | 499 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3670 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 994 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 180 | 0.020 |
Why?
|
| Premature Birth | 1 | 2020 | 1829 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 389 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3314 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 513 | 0.020 |
Why?
|
| Ischemia | 1 | 2016 | 1922 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 700 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2417 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3335 | 0.020 |
Why?
|
| Multiple Sclerosis | 2 | 2001 | 3212 | 0.020 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 40 | 0.020 |
Why?
|
| Limulus Test | 1 | 2005 | 19 | 0.020 |
Why?
|
| Medication Errors | 1 | 1992 | 786 | 0.020 |
Why?
|
| Rural Population | 1 | 2017 | 2317 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2008 | 824 | 0.020 |
Why?
|
| Work | 1 | 2007 | 195 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1603 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 1999 | 3614 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1969 | 490 | 0.020 |
Why?
|
| Psychological Tests | 1 | 1988 | 643 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 1013 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 27178 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20680 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 784 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Bronchi | 1 | 1989 | 844 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 869 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13635 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2006 | 199 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 1988 | 811 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2011 | 3623 | 0.010 |
Why?
|
| Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 164 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10723 | 0.010 |
Why?
|
| Personality | 1 | 1988 | 560 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 78 | 0.010 |
Why?
|
| Diagnosis | 1 | 1965 | 158 | 0.010 |
Why?
|
| Beds | 1 | 2004 | 48 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9594 | 0.010 |
Why?
|
| Urography | 1 | 1965 | 316 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 591 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 1936 | 0.010 |
Why?
|
| Germany | 1 | 2005 | 882 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1989 | 836 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 919 | 0.010 |
Why?
|
| T-Lymphocytes | 3 | 1990 | 10262 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 676 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5786 | 0.010 |
Why?
|
| Health Behavior | 1 | 2014 | 2649 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8039 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1995 | 4501 | 0.010 |
Why?
|
| Oocysts | 1 | 2002 | 16 | 0.010 |
Why?
|
| Medicare | 1 | 2000 | 6816 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8320 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1965 | 318 | 0.010 |
Why?
|
| Connecticut | 1 | 2002 | 365 | 0.010 |
Why?
|
| Ownership | 1 | 2004 | 338 | 0.010 |
Why?
|
| Plant Roots | 1 | 2002 | 122 | 0.010 |
Why?
|
| Epitopes | 1 | 2008 | 2523 | 0.010 |
Why?
|
| Mass Screening | 1 | 2017 | 5445 | 0.010 |
Why?
|
| Antigens | 2 | 2006 | 1438 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12122 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5995 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 586 | 0.010 |
Why?
|
| Travel | 1 | 2006 | 806 | 0.010 |
Why?
|
| Telecommunications | 1 | 2001 | 79 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23707 | 0.010 |
Why?
|
| Agriculture | 1 | 2002 | 186 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10087 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2008 | 3945 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1999 | 42 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 2393 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1965 | 927 | 0.010 |
Why?
|
| Utah | 1 | 1999 | 130 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1409 | 0.010 |
Why?
|
| Angiography | 1 | 1965 | 1599 | 0.010 |
Why?
|
| Hospitals | 1 | 1992 | 3887 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2006 | 2741 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8062 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1991 | 3711 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2677 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 3110 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2000 | 536 | 0.010 |
Why?
|
| Vegetables | 1 | 2002 | 1200 | 0.010 |
Why?
|
| Israel | 3 | 1969 | 725 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1995 | 50 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9297 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 4020 | 0.010 |
Why?
|
| Common Cold | 1 | 1995 | 63 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 1995 | 128 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1995 | 214 | 0.010 |
Why?
|
| Workload | 1 | 2001 | 850 | 0.010 |
Why?
|
| Philadelphia | 1 | 1995 | 267 | 0.010 |
Why?
|
| Long-Term Care | 1 | 1999 | 630 | 0.010 |
Why?
|
| Workplace | 1 | 2001 | 873 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 1984 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 5996 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1965 | 2097 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 8725 | 0.010 |
Why?
|
| Psoriasis | 1 | 2001 | 919 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1993 | 83 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 1993 | 59 | 0.010 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1993 | 200 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1993 | 439 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1993 | 192 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1997 | 12767 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2823 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 14062 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1995 | 6219 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1981 | 355 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1991 | 250 | 0.010 |
Why?
|
| Body Constitution | 1 | 1990 | 272 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1989 | 152 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 1999 | 1845 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 30188 | 0.000 |
Why?
|
| Microglia | 1 | 1997 | 1370 | 0.000 |
Why?
|
| Academic Medical Centers | 1 | 1999 | 2780 | 0.000 |
Why?
|
| Airway Resistance | 1 | 1989 | 407 | 0.000 |
Why?
|
| Minority Groups | 1 | 1995 | 1208 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1999 | 2776 | 0.000 |
Why?
|
| Health Care Costs | 1 | 2001 | 3240 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3269 | 0.000 |
Why?
|
| Pericardiectomy | 1 | 1966 | 45 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 3734 | 0.000 |
Why?
|
| Survival Rate | 1 | 2000 | 12821 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12402 | 0.000 |
Why?
|
| Pericarditis | 1 | 1966 | 135 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11033 | 0.000 |
Why?
|
| Desensitization, Immunologic | 1 | 1969 | 545 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17595 | 0.000 |
Why?
|
| Macrophages | 1 | 1997 | 5771 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23588 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1991 | 6014 | 0.000 |
Why?
|
| Health Status | 1 | 1993 | 4084 | 0.000 |
Why?
|
| Apoptosis | 1 | 1995 | 9512 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1980 | 915 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1981 | 852 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7558 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1991 | 12966 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1980 | 3612 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1980 | 4779 | 0.000 |
Why?
|
| Neoplasms | 1 | 1993 | 22349 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1966 | 15794 | 0.000 |
Why?
|